Contracts › 140D0426C0122
140D0426C0122: Arpa-H Snc Shield Sttr Phase Ii
Awarded to Snc Therapeutics, Inc. by Departmental Offices.
$3.5Mobligated
$3.5Mpotential value
27 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 140D0426C0122 |
|---|---|
| Awardee | Snc Therapeutics, Inc. |
| Awarding agency | Departmental Offices |
| Awarding office | IBC ACQ SVCS DIRECTORATE (00004) |
| NAICS | 541713 Research and Development in Nanotechnology |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | IL |
| Offers received | 2 |
| Period of performance | 24 September 2026 to 27 September 2028 |
| Potential end | 27 September 2028 |
| Estimated recompete solicitation | ~Q1 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541713 contracts · All expiring contracts · USASpending record